DigiPath

(OTC: DIGP)
Healthcare  |  Diagnostics & Research
0.16 -0.0054 -3.26%
Stock Price | May 24, 2019, 2:48 p.m.
3 Followers
Bid: 0.16
Ask: 0.18
Prev. Close: 0.166
52 Week Low:
52 Week High:
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

DigiPath Inc is a US-based company which is engaged in providing pharmaceutical-grade analysis and testing cannabis education and training and brings unbiased cannabis news coverage to the cannabis industry. The company screens medicinal cannabis for potentially harmful contaminants, including solvents, pesticides, mold and yeast, heavy metals such as mercury, arsenic, lead, and cadmium, biological toxins, such as aflatoxin, ricin, botulinum toxin and microbial contaminants including E. coli, salmonella, Aspergillus, and fungus. It also tests cannabis for its quality, potency, and cannabinoid and terpene profiles, which determine the suitability of specific cannabis strains for the treatment of specific ailments.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 01/23/18

27 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 01/22/18

73 Comments
1 year ago

Premium Focus List Review - 01/14/18

4 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 01/16/18

20 Comments
1 year ago

Premium Cannabis Stocks Review - Pre-Market Edition 01/11/18

25 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 01/08/18

42 Comments
1 year ago

Premium Weekly Review 01/05/18

46 Comments
1 year ago

Premium Mid-Week Chat - 01/03/18

32 Comments
1 year ago

Premium Cannabis Stocks Review - Weekend Edition 01/02/18

49 Comments
1 year ago

Premium Weekly Review 12/29/17

2 Comments
1 year ago